Ascendis Pharma A/S announced that its Board of Directors approved a plan to allocate approximately $25 million in the first quarter of 2025 for a share repurchase program and the net settlement of ...
– Expected use of approximately $25 million in first quarter of 2025 intended to preserve approximately 200,000 ADSs held as treasury shares In addition, the Company plans to apply net settlement of ...
WYOMISSING, Pa.--(BUSINESS WIRE)--PENN Entertainment, Inc. (“PENN” or the “Company”) (Nasdaq: PENN) announced today the final settlement terms of its previously announced note repurchase transactions, ...
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced that it will enter today into two ...
Waltham, Mass., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM, “Nano Dimension” or the “Company”), a leading supplier of Additively ...
Shares of Albertsons (ACI) were under pressure ahead of Tuesday’s open as mixed fourth-quarter results—in which both sales and adjusted profits improved from a year ago—were overshadowed by a ...
Examples of such statements include, but are not limited to, statements relating to (i) the planned Share Repurchase Program, (ii) the planned Net Settlement of RSUs, (iii) Ascendis’ ability to apply ...
Hosted on MSN
Albertsons' opioid settlement widens Q4 GAAP loss, overshadows dividend, share repurchase hike
Shares of Albertsons (ACI) were under pressure ahead of Tuesday’s open as mixed fourth-quarter results—in which both sales and adjusted profits improved from a year ago—were overshadowed by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results